You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xofigo

Showing 1 - 25 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors, Castration-Resistant Trial in Multiple Locations (Radium-223 dichloride (Xofigo, BAY 88-8223))

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radium-223 dichloride (Xofigo, BAY 88-8223)
  • Multiple Locations, Japan
    (unnamed)
Feb 2, 2023

Patients and Other Factors Which May Contribute to Survival

Completed
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Whippany, New Jersey
    Bayer Flatiron Xofigo Registry database
Mar 17, 2022

How Radium-223 Dichloride,Alpha Particle-emitting Radioactive

Recruiting
  • Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Taiwan
    Many locations
Aug 19, 2022

Treatment Satisfaction With Ra-223 in Japan

Active, not recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Japan
    Many Locations
Jan 12, 2023

Prostate Gland Cancer, Which Spreads to Other Parts of Body, Who

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Radium-223 (Xofigo, BAY88-8223)
  • +2 more
  • Whippany, New Jersey
    US Flatiron prostate cancer database
Dec 8, 2021

Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

Not yet recruiting
  • Metastatic Prostate Cancer
  • (no location specified)
Mar 6, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

Learn More About How Radium-223 Affects Quality of Life of

Recruiting
  • Prostate Cancer
  • Radium-223-dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Colombia
    Many Locations
Jan 19, 2023

Learn More About How Radium-223 is Being Used With Other

Active, not recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium 223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Denmark
  • +2 more
Jan 16, 2023

Radium-223 Treated Castration Resistant Prostate Cancer Bone

Completed
  • Castration-Resistant Prostatic Cancer
  • Radium-223 dichloride, (Xofigo, BAY88-8223)
  • Multiple Locations, Germany
    (unnamed)
Nov 1, 2021

Prostate Cancer Trial in Boston (Radium-223, Pembrolizumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 31, 2022

Radium-223 is and How Well it Works in Chinese Advanced Prostate

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, China
    Many locations
Aug 10, 2022

Healthcare Services and Way Disease is Cared for in Canadian

Completed
  • Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Canada
    Multiple Locations
Jun 22, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Overall Survival and Effectiveness Predictors for mCRPCReal Life

Completed
  • Prostatic Neoplasms, Castration-Resistant
  • Radium-223-dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Germany
    Many Locations
Nov 1, 2021

Prostate Cancer Trial in Houston (Alpharadin)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 16, 2022

Non Small Cell Lung Cancer With Bone Metastatses Trial in Providence (Xofigo)

Completed
Has Results
  • Non Small Cell Lung Cancer With Bone Metastatses
  • Xofigo
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
Jan 29, 2021

Prostate Cancer Metastatic to Bone Trial in Salt Lake City (Radium Ra 223 Dichloride, Radiation)

Active, not recruiting
  • Prostate Cancer Metastatic to Bone
  • Radium Ra 223 Dichloride
  • Radiation
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Sep 20, 2021

Breast Cancer Trial in Houston (Ra-223 dichloride, Denosumab, Hormone Therapy)

Completed
Has Results
  • Breast Cancer
  • Ra-223 dichloride
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 5, 2021

Multi-academic Center Study of Xofigo Patients

Completed
  • Prostate Cancer, Castration Resistant
  • Xofigo
  • +2 more
  • Whippany, New Jersey
    Bayer US
Oct 20, 2020

Retrospective Data of XOFIGO

Completed
  • Prostate Cancer
  • +2 more
  • clinical database
  • Montpellier, Herault, France
  • +7 more
Aug 14, 2020

Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

Recruiting
  • Prostate Adenocarcinoma
  • Leuprolide Acetate
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Gather More Information About Bone Fractures and Survival in

Completed
  • Metastatic Castration-Resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Other standard care
  • Database Study, Sweden
    Database Study
Jul 1, 2021

Bone Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Linz, Oberösterreich, Austria
  • +15 more
Aug 24, 2022

Health-related Quality of Life, Psychological Distress and

Completed
  • Castrate Resistant Prostate Cancer
  • Bone Metastases
  • 's-Hertogenbosch, Netherlands
  • +10 more
Jul 29, 2021